330440001: Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Immunomodulator-containing product\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Immunomodulator-containing product\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Product containing only betamethasone and neomycin (medicinal product)\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Immunomodulator-containing product\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Neomycin-containing product\Neomycin-containing product in ocular dose form\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Neomycin-containing product\Betamethasone- and neomycin-containing product\Product containing only betamethasone and neomycin (medicinal product)\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Neomycin-containing product\Betamethasone- and neomycin-containing product\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Product containing only betamethasone and neomycin (medicinal product)\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Product containing only betamethasone and neomycin (medicinal product)\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by disposition (product)\Hormone-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)

\Medicinal product categorized by structure (product)\Steroid-containing product\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Steroid-containing product\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Product containing only betamethasone and neomycin (medicinal product)\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Steroid-containing product\Product containing pregnane (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Product containing only betamethasone and neomycin (medicinal product)\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Product containing fluorinated corticosteroid (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Product containing only betamethasone and neomycin (medicinal product)\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Steroid-containing product\Corticosteroid and/or corticosteroid derivative-containing product\Product containing glucocorticoid (product)\Product containing betamethasone (medicinal product)\Betamethasone- and neomycin-containing product\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Product containing glycoside (product)\Product containing aminoglycoside (product)\Neomycin-containing product\Neomycin-containing product in ocular dose form\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Product containing glycoside (product)\Product containing aminoglycoside (product)\Neomycin-containing product\Betamethasone- and neomycin-containing product\Product containing only betamethasone and neomycin (medicinal product)\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Medicinal product categorized by structure (product)\Product containing glycoside (product)\Product containing aminoglycoside (product)\Neomycin-containing product\Betamethasone- and neomycin-containing product\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)

\Product manufactured as ocular dose form (product)\Product containing betamethasone in ocular dose form (medicinal product form)\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)
\Product manufactured as ocular dose form (product)\Neomycin-containing product in ocular dose form\Betamethasone- and neomycin-containing product in ocular dose form\Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)\Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3692832010 Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3692834011 Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

467927013 Betamethasone sodium phosphate+neomycin sulphate 0.1/0.5% eye ointment en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

467927013 Betamethasone sodium phosphate+neomycin sulphate 0.1/0.5% eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

467928015 Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

467928015 Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

720723013 Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1192137012 Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

1192137012 Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3692832010 Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3692833017 Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3692834011 Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Is a	Betamethasone+neomycin sulfate	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Is a	Miscellaneous eye preparations	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Betamethasone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Adrenal hormone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Is a	Topical neomycin	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Is a	Topical betamethasone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Betamethasone sodium phosphate	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Corticosterone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Neomycin sulphate	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	anti-infectieux cutané	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Adrenal hormone agent	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Glucocorticoid hormone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bactericide	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Local anti-infective	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Is a	Product containing betamethasone in ophthalmic dosage form	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Is a	Product containing neomycin in ophthalmic dosage form	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has manufactured dose form	Eye ointment (product)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Is a	Betamethasone- and neomycin-containing product	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Count of base of active ingredient	deux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has concentration strength numerator value	cinq	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has concentration strength numerator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has precise active ingredient	Betamethasone sodium phosphate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has precise active ingredient	Neomycin sulphate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has concentration strength denominator unit (attribute)	g	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has basis of strength substance (attribute)	Betamethasone sodium phosphate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has concentration strength numerator unit	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has concentration strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has basis of strength substance (attribute)	Neomycin sulphate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has concentration strength numerator unit	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has concentration strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Has concentration strength denominator unit (attribute)	g	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Is a	Product containing only betamethasone and neomycin in ocular dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	Plays role	Antibacterial therapeutic role (role)	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3692832010	Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3692834011	Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
467927013	Betamethasone sodium phosphate+neomycin sulphate 0.1/0.5% eye ointment	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
467927013	Betamethasone sodium phosphate+neomycin sulphate 0.1/0.5% eye ointment	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
467928015	Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
467928015	Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
720723013	Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1192137012	Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (product)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1192137012	Betamethasone sodium phosphate+neomycin sulfate 0.1/0.5% eye ointment (product)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3692832010	Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3692833017	Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3692834011	Betamethasone sodium phosphate 1 mg/g and neomycin sulfate 5 mg/g eye ointment	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core